In Radionuclide imaging the most useful radiopharmaceutical for skeletal imaging is –
**Core Concept**
Radionuclide imaging, specifically skeletal imaging, relies on the uptake and retention of a radiopharmaceutical by bone tissue. The ideal radiopharmaceutical for skeletal imaging should have high affinity for bone, allowing for clear visualization of bone structures.
**Why the Correct Answer is Right**
Technetium-99m-methyl diphosphonate (Tc-99m-MDP) is the most commonly used radiopharmaceutical for skeletal imaging. It is taken up by bone tissue through the action of osteoblasts, which incorporate the phosphonate group into bone hydroxyapatite. This results in a high concentration of the radiopharmaceutical in areas of active bone turnover, such as fractures, tumors, or osteomyelitis. The high sensitivity and specificity of Tc-99m-MDP make it an excellent choice for skeletal imaging.
**Why Each Wrong Option is Incorrect**
**Option A:** Technetium-99m-pentetate (Tc-99m-pentetate) is a chelating agent used for renal imaging, not skeletal imaging.
**Option B:** Gallium-67 citrate (Ga-67 citrate) is a radiopharmaceutical used for imaging infections, tumors, and inflammation, but it is not specific for skeletal imaging.
**Option C:** Indium-111 oxine (In-111 oxine) is a radiopharmaceutical used for imaging infections and inflammation, but it is not the most useful for skeletal imaging.
**Clinical Pearl / High-Yield Fact**
When interpreting skeletal imaging studies, remember that increased uptake of Tc-99m-MDP may indicate areas of active bone turnover, such as fractures, tumors, or osteomyelitis, while decreased uptake may suggest osteoporosis or other conditions affecting bone density.
**Correct Answer: C. Tc-99m-MDP**